Michael Myers
Chief Executive Officer at QUOIN PHARMACEUTICALS, LTD.
Net worth: 8 890 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hugh McTavish | M | 61 |
SquareX Pharmaceuticals Corp.
 SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | 12 years |
| Denise Carter | F | 55 |
Fuisz Technologies Ltd.
 Fuisz Technologies Ltd. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd. is a private company that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. The company is based in Chantilly, VA. Fuisz Technologies was acquired by Biovail Corp. on November 12, 1999 for $145.48 million.
Innocoll, Inc.
 Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | 23 years |
| Michael Sember | M | - |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 15 years |
| Kenneth Dill | M | - |
Wellesley Pharmaceuticals LLC
 Wellesley Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA. | - |
| Natalie Leong | F | 39 |
Quoin Pharmaceuticals, Inc.
 Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | 3 years |
| Dennis Langer | M | 73 |
Quoin Pharmaceuticals, Inc.
Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | 3 years |
| Derek Overstreet | M | 37 |
Sonoran Biosciences, Inc.
| - |
| Joseph Cooper | M | 66 |
Sonoran Biosciences, Inc.
| 6 years |
| Gordon Dunn | M | 60 |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | 8 years |
| Anthony Culverwell | M | 68 | 3 years | |
| Mark W. Schwartz | M | 68 |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | 2 years |
| Arkadiusz Dudek | M | 59 |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | 6 years |
| Wayne Danson | M | 70 |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | 2 years |
| Omer Karahan | M | - |
Wellesley Pharmaceuticals LLC
Wellesley Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA. | - |
| Candan Karabagli | M | - |
Wellesley Pharmaceuticals LLC
Wellesley Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA. | - |
| Christopher Lineberry | M | - |
Wellesley Pharmaceuticals LLC
Wellesley Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA. | - |
| Denise Carter | F | - |
Quoin Pharmaceuticals, Inc.
Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | - |
| Peter A. Lankau | M | 71 |
Quoin Pharmaceuticals, Inc.
Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | - |
| Kwang Lee | M | 50 |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Daniel | M | 72 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 19 years |
| James T. O'Brien | M | 85 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 2 years |
| Thomas Gerard Lynch | M | 67 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 11 years |
| Mary Martin | M | - |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 14 years |
| Jonathan Symonds | M | 66 |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | - |
| Peter Gray | M | 69 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 6 years |
| David Brennan | M | 70 |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | - |
| Donal Tierney | M | - |
Fuisz Technologies Ltd.
Fuisz Technologies Ltd. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd. is a private company that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. The company is based in Chantilly, VA. Fuisz Technologies was acquired by Biovail Corp. on November 12, 1999 for $145.48 million. | 1 years |
| Shumeet Banerji | M | 63 |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | - |
| Guriqbal S. Basi | M | 67 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | 22 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 23 | 79.31% |
| Ireland | 7 | 24.14% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Myers
- Personal Network